期刊文献+

非小细胞肺癌组织中CD1α、CD83阳性树突状细胞浸润的临床意义 被引量:2

下载PDF
导出
摘要 目的探讨CD1α、CD83阳性树突状细胞在肺癌组织中的浸润情况及其临床意义。方法采用流式细胞术检测49例非小细胞肺癌组织,对应的49例癌旁组织,10例炎性假瘤中树突状细胞表面分子CD1α和CD83的表达,分析CD1α和CD83表达水平与肺癌临床分期、病理类型、组织学分级和淋巴结转移的相关性。结果(1)树突状细胞CD1α的表达率在肺癌组织、癌旁组织及炎性假瘤中无显著性差异(P>0.05);(2)肺癌组织中CD83阳性树突状细胞的比例明显低于癌旁组织及炎性假瘤(P<0.05);(3)肺癌组织中树突状细胞CD83的表达率在不同临床分期、病理类型和组织学分级中无显著性差异(P>0.05),但与肺癌的局部淋巴结转移有关(P<0.05)。结论(1)肺癌组织中CD83阳性树突状细胞较癌旁组织及炎性组织中减少;(2)肺癌组织中CD83阳性树突状细胞减少与肿瘤淋巴转移密切相关。
出处 《江苏医药》 CAS CSCD 北大核心 2007年第4期386-387,共2页 Jiangsu Medical Journal
基金 江苏省社会发展基金(200038) 江苏省医学重点人才基金(RC2002032)
  • 相关文献

参考文献7

  • 1Moser M.Dendritic cells in immunity and tolerance-do they display opposite functions[J]? Immunity,2003,19(1):5-8.
  • 2Ghiringhelli F,Puig PE,Roux S,et al.Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4^+CD25^+ regulatory Tcell proliferation[J].J Exp Med,2005,202(7):919-929.
  • 3Paul J,Herman W.Dendritic cells and prospects for transplantation tolerance[J].Curr Opin Immu,2000,12(5):528-535.
  • 4Misra N,Bayry J,Lacroix-Desmazes S,et al.Cutting edge:human CD25+CD4+ T cells restrain the maturation and antigen-presenting function of dendritic cells[J].Immunol,2004,172(8):4676-4680.
  • 5马占龙,邓红.VEGF及其促肿瘤血管形成作用的研究进展[J].江苏医药,2004,30(1):50-51. 被引量:20
  • 6赵瑞景,冯惠东,王秀荣,胡代伦,朱铁年.树突状细胞浸润与肺癌预后相关性研究[J].中国肺癌杂志,2002,5(2):112-114. 被引量:11
  • 7Kono K,Takahsahi A,Ichihara F,et al.Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer:a randomized trial[J].Clin Cancer Res,2002,8(6):1767-1771.

二级参考文献16

  • 1左连富.流式细胞术检测石蜡包埋肿瘤细胞DNA含量样品制备方法[J].中华病理学杂志,1998,17(3):232-232.
  • 2[1]Ian Zachary.Molecules in focus vascular endothelial growth factor.The International Journal of Biochemistry & Cell Biology,1998,30:1169-1174.
  • 3[2]Maxwell PH.Activation of the HIF pathway in cancer.Curr Opin Genet Dev,2001,11:293-299.
  • 4[3]Christitane BH,Edurne B,Jacques P.Hypoxia:the tumor's gateway to progression along the angiogenic pathway.Trends in Cell Biology,2001,11:32-36.
  • 5[4]Teraoka H,Nishihara T,Ohira M,et al.Enhanced VEGF production decreased immunogenicity induced by TGF-β1 promote liver metastasis of pancreatic cancer.Br J Cancer,2001,85:612-617.
  • 6[5]Ravi R,Mookergee B,Bhujwalla Z,et al.Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α.Genes Dev,2000,14:34-44.
  • 7[6]Soumitro P,Kaustubh D,Dababrata M.Central role of P53 on regulation of vascular permeability factor/vascular endothelial factor(VPF/VEGF)expression in mammary crcinoma.Cancer Research,2001,61:6952-6956.
  • 8[7]Ikeda N,Adachi M,Taki T,et al.Prognostic significance of angiogenesis in human pancreatic cancer.Br J Cancer.1999,79:1553-1563.
  • 9[8]Fujimoto J,Sakaguchi R,Hirose R,et al.Expression of vascular endothelial growth factor(VEGF)and its mRNA in uterine cancers.Br J Cancer,1999,80:827-833.
  • 10[9]Torahiko J,Michael L,Calyman DDS.Antisense inhibition of vascular endothelial growth factor in human head and neck squamous cell carcinoma.Head & Neck,2000,8:483-487.

共引文献29

同被引文献22

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部